Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
University of Nebraska
M.D. Anderson Cancer Center
West Virginia University
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Columbia University
University of Illinois at Chicago
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
Massachusetts General Hospital
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
Massachusetts General Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Otsuka Pharmaceutical Development & Commercialization, Inc.
Northside Hospital, Inc.
Northside Hospital, Inc.
Case Comprehensive Cancer Center
Northside Hospital, Inc.
M.D. Anderson Cancer Center